Your session is about to expire
← Back to Search
Mozobil for Neutropenia
Study Summary
This trial is testing whether a drug called Mozobil is safe and effective to treat neutropenia in patients with WHIMS.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My male partner has had a vasectomy confirmed to prevent sperm production.You have a condition called neutropenia, where your body doesn't produce enough infection-fighting cells, and the doctor doesn't think this medication will help you.I have a serious heart rhythm problem or defect.My kidneys are failing, needing dialysis or my creatinine clearance is below 15 mL/min.I am willing to give samples of my blood and DNA for research.I am willing to stop taking certain medications for my white blood cell count for the study.I use condoms as a form of contraception.I have not had a severe infection in my medical history.I am under 18 years old.I am not willing to undergo the tests or procedures required by this study.I do not have signs of an infection right now.I have WHIMS and have had a severe infection.I use a diaphragm or cervical cap with spermicide for birth control.I have never been diagnosed with WHIMS.You have an intrauterine device (IUD) inserted in your uterus.I am between 18 and 75 years old.I am using an FDA-approved birth control method.
- Group 1: Treatment Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this scientific experiment currently accept elderly participants?
"The trial stipulates that the minimum permissible age for enrollment is 18 and the uppermost limit of age set by the inclusion criteria is 75."
Is enrollment for this clinical experiment still available?
"Clinicialtrials.gov cites that this medical trial is actively pursuing patients, having been posted on the 6th of January 2010 and receiving its last update on the 17th of September 2022."
What is the upper limit of participants for this trial?
"Affirmative, the information on clinicaltrials.gov suggests that this trial is presently recruiting patients. It was first posted 6th January 2010 and most recently updated 17th September 2022 - with a requirement to recruit 20 participants from two different sites."
Under what criteria may individuals enroll in this research program?
"This investigation necessitates the enrollment of 20 leukopenia sufferers aged between 18 and 75. To be eligible, they must use an FDA-approved contraceptive technique such as oral contraception or a condom with spermicide, have access to personal care physicians and not be pregnant or lactating."
What distinct investigations have been carried out regarding Treatment Arm?
"Currently, 18 studies are being conducted to assess the efficacy of Treatment Arm. None of these active trials have progressed to Phase 3 yet. Most investigations into this treatment take place in Seattle, Washington but 54 other sites across the globe are also researching Treatment Arm."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger